Frontline Findings Put Fresh Focus on Immunotherapy in NSCLC – OncLive
OncLive |
Frontline Findings Put Fresh Focus on Immunotherapy in NSCLC
OncLive While frontline immunotherapy has shown promise for some patients with NSCLC, there is a need to further improve outcomes through combinations. Several trials are currently looking at approved checkpoint inhibitors with targeted therapies, other … |
